Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat

Cell and Tissue Research

Volumn 284, Issue 3, 1996, Pages 495-500

  Walsh, Raymond J ^a,b   Weglicki, William B ^a   Correa De Araujo, Rosaly ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Aorta; Binding sites; Heart; Magnesium; Neuropeptide immunocytochemistry; Rat (Wistar); Receptors, membrane; Substance P; Valves

Indexed keywords

PROLACTIN; SUBSTANCE P RECEPTOR;

ANIMAL TISSUE; AORTA; ARTICLE; AUTORADIOGRAPHY; CONNECTIVE TISSUE; CORONARY ARTERY; FROZEN SECTION; HEART; MAGNESIUM DEFICIENCY; MALE; MICROSCOPY; NONHUMAN; PARASYMPATHETIC GANGLION; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; ARTERIES; AUTORADIOGRAPHY; BINDING SITES; CARDIOMYOPATHIES; CORONARY VESSELS; HEART VALVES; MAGNESIUM DEFICIENCY; MALE; MUSCLE FIBERS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; RATS; RATS, WISTAR; SILVER STAINING; SUBSTANCE P;

ANIMALIA;

EID: 0029969988     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050611     Document Type: Article

References (21)

1. Bloom S (1986) Effects of magnesium deficiency on the pathogenesis of myocardial infarction. Magnesium 5: 154-164
2. Dikranian K, Loesch A, Burnstock G (1994) Localization of nitric oxide synthase and its colocalization with vasocative peptides in coronary and femoral arteries. J Anat 184:583-590
3. D'Orleans-Juste P, Dion S, Drapeau G, Regoli D (1985a) Differences receptors are involved in the endothelium-mediated relaxation and the smooth muscle concentration of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol 125:37-44
4. D'Orleans-Juste P, Dion S, Mizrahi J, Regoli D (1985b) Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol 114:9-21
5. Gottlieb SS (1989) Importance of magnesium in congestive heart failure. Am J Cardiol 6.3:39G-42G
6. Hoover DB, Hancock JC (1988) Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P. J Auton Nerv Syst 23:189-197
7. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR (1990) Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 120:672-676
8. Kleinman JC, Donahue RP, Harris HI, Finucane FF, Madans JH, Brock DB (1988) Mortality among diabetics in a national sample. Am J Epidemiol 128:389-401
9. Lundberg JM, Franco-Cereceda A, Hua X, Hokfelt T, Fischer JA (1985) Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 108:315-319
10. Milner P, Ralevic V, Hopwood AM, Feher E, Lincoln J, Kirkpalrick KA, Burnstock G (1989) Ultrastructural localization of substance P and choline acetyltransferase in endothelial cells of the rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 45:121-125
11. Reinecke M, Weihe E, Forssman WG (1980) Substance P-immunoreactive nerve fibers in the heart. Neurosci Lett 20:265-269
12. Rude RK (1992) Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med 92:217-219
13. Seelig M (1989) Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations of magnesium and chloride loss in refractory potassium repletion. Am J Cardiol 63:4G-21G
14. Singh RB (1990) Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death. Magnes Trace Elem 9:143-151
15. Skofitsch G, Savitt JM, Jacobowitz DM (1985) Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry 82:5-8
16. Stephenson JA, Summers RJ (1987) Autoradiographic analysis of receptors on vascular endothelium. Eur J Pharmacol 134:35-43
17. Stephenson JA, Burcher E, Summers RJ (1986) Autoradiographic demonstration of endothelium-dependent 125-I Bolton-Hunter substance P binding to dog carotid artery. Eur J Pharmacol 124:377-378
18. Weglicki WB, Phillips TM (1992) Puthobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 263:R734-R737
19. Weglicki WB, Mak IT, Phillips TM (1994a) Blockade of cardiac inflammation in Mg deficiency by substance P receptor inhibition. Circ Res 74:1009-1013
20. Weglicki WB, Mak IT, Stafford RE, Dickens BE, Cassidy MM, Phillips TM (1994b) Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem 130:103-109
21. Ziehe M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA (1990) Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264-278